×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
💹
Economics
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Economics
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Investment: TREM2 Therapeutics Investment Landscape
investment
1,150 words
KG: ent-gene-28e2cb01
2026-03-24
kind:investment
section:unclassified
state:published
Contents
TREM2 Therapeutics Investment Landscape
🔬
Protein Info
Gene Symbol
ent-gene-28e2cb01
Summary
Page for TREM2 Therapeutics Investment Landscape
KG Connections
5
knowledge graph edges
Databases
GeneCards
UniProt
NCBI Gene
HPA
STRING
Knowledge Graph
Related Hypotheses (10)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.59
TREM2-mediated microglial tau clearance enhancement
Score: 0.80
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
APOE-TREM2 Interaction Modulation
Score: 0.74
Purinergic Signaling Polarization Control
Score: 0.71
Mechanosensitive Ion Channel Reprogramming
Score: 0.70
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
TREM2-Dependent Microglial Senescence Transition
Score: 0.86
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.70
Show 5 more
Related Analyses (17)
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · completed
Neuroinflammation and microglial priming in early Alzheimer'
neurodegeneration · archived
Neuroinflammation and microglial priming in early AD
neurodegeneration · completed
Does SYK activation provide neuroprotection or exacerbate ne
neurodegeneration · archived
What are the optimal timing windows for TREM2 agonism vs ant
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · archived
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
TREM2 Therapeutic Strategy Post-INVOKE-2
neurodegeneration · completed
Show 12 more
Related Experiments (30)
TREM2 KO amyloid pathology study
validation · completed · Score: 0.75
TREM2 KO amyloid pathology study
validation · completed · Score: 0.75
TREM2 KO amyloid pathology study
validation · in_progress · Score: 0.75
TREM2 KO amyloid pathology study
validation · completed · Score: 0.75
TREM2 KO amyloid pathology study
validation · completed · Score: 0.75
TREM2 KO amyloid pathology study
validation · in_progress · Score: 0.75
TREM2 KO amyloid pathology study
validation · completed · Score: 0.75
s:** - GPR32 knockout in microglia should worsen neuroinflam
falsification · proposed · Score: 0.40
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40
s:** - Compare tau strain spreading in EXT1/EXT2 conditional
falsification · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.40
Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy
validation · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Experiment: Autoimmune Hypothesis Testing in AD
clinical · proposed · Score: 0.40
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
DLB Cognitive Fluctuation Mechanism Experiment
clinical · proposed · Score: 0.40
Genetic Risk Modifiers in DLB Phenotype
clinical · proposed · Score: 0.40
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.40
Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.40
FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation
clinical · proposed · Score: 0.40
Microglial Aging and Immune Memory in Neurodegeneration — Tr
validation · proposed · Score: 0.40
Microglial Contributions to Huntington's Disease Pathogenesi
validation · proposed · Score: 0.40
Mixed Pathology Effects on Parkinson's Disease Progression a
clinical · proposed · Score: 0.40
Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40
Prodromal Parkinson's Disease Biomarker Development — Early
clinical · proposed · Score: 0.40
Show 25 more
See Also (15)
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 6 hypotheses
Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 6 hypotheses
Therapeutic Targets in Neurodegeneration
mechanism · Pages share 6 hypotheses
Sex Differences in Neurodegeneration
mechanism · Pages share 6 hypotheses
Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 6 hypotheses
Retinal Degeneration Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
Microglial Priming Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
Lipid Metabolism Dysregulation in Neurodegeneration
mechanism · Pages share 6 hypotheses
IL-1 Signaling Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
HMGB1 Signaling in Neurodegeneration
mechanism · Pages share 6 hypotheses
gp130/IL-6 Family Cytokine Signaling in Neurodegenerati
mechanism · Pages share 6 hypotheses
Geniposide for Alzheimer's disease - immune biomarker t
mechanism · Pages share 6 hypotheses
Galectin-3 Mechanism in Neurodegeneration
mechanism · Pages share 6 hypotheses
Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 6 hypotheses
Dystrophic Neurites in Neurodegeneration
mechanism · Pages share 6 hypotheses
Show 10 more
Knowledge Graph (5 edges)
ent-gene-28e2cb01
expressed_in
microglia
ent-gene-28e2cb01
data_in
ad_genetic_risk_loci:TREM2
ent-gene-28e2cb01
data_in
benchmark_ot_ad_answer_key:TREM2
ad_genetic_risk_loci:TREM2
data_in
ent-gene-28e2cb01
benchmark_ot_ad_answer_key:TREM2
data_in
ent-gene-28e2cb01
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)